Rebee, a Singapore-based healthtech start-up, has successfully raised $1.18 million in a Series Seed funding round to expand its digital home physiotherapy services across Southeast Asia. The funding, led by prominent investors such as Paragon Ventures I, SEEDS Capital, 1337 Capital 1, The LAB9, and C-shark SG, will support Rebee’s mission to make physiotherapy more accessible and convenient for patients recovering from musculoskeletal pain.
The start-up offers a digital platform combined with wearable sensor technology, allowing patients to recover safely and effectively from the comfort of their homes. This approach addresses a significant gap in healthcare accessibility, particularly for those dealing with post-surgery, chronic, or acute pain. “Musculoskeletal pain is one of the most common and costly health challenges globally, yet access to proper physiotherapy remains inconsistent and inconvenient,” said Lincoln Dacy, Founder and CEO of Rebee.
The newly acquired funds will be utilised to enhance product development, expand clinical partnerships in Singapore, Malaysia, and Australia, and increase outreach to healthcare providers and insurers. Rebee’s platform, which features intelligence-guided exercise correction and real-time progress tracking, has already gained traction among Singapore hospitals and orthopaedic specialists.
Tan Xinhui, General Partner from Paragon Ventures I, expressed confidence in Rebee’s potential, stating, “Their technology addresses a critical gap in healthcare access and affordability, and we’re proud to support their next stage of growth.” As Rebee continues to innovate, it aims to redefine digital health recovery and set a new standard in remote physiotherapy.
“`
